The University of South Florida's department of neurosurgery and brain repair has received a patent for a cell transplantation method that uses human umbilical cord-blood cells in combination with a compound called mannitol to treat neurodegenerative diseases. Saneron CCEL Therapeutics, a biotech research and development company, has licensed the technology.

Related Summaries